Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
24.06.24
/
50%
€49.60
Target price
24.06.25
€60.52
Performance (%)
0.40%
Price
06.09.24
€48.80
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc. is nearly unchanged. This prediction currently runs until 24.06.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | -6.154% | -6.154% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JPMorgan Chase & Co. from $77.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-3.37%
06.09.24
06.09.24